Pui Ying Chan

4PUBLICATIONS
28CO-AUTHORS
Molecular targetsGene and molecular therapyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 20, 2026
Pegargiminase Suppresses the Fanconi Anemia Pathway and Promotes Melphalan-Induced DNA Double-Strand Breaks in Uveal Melanoma.

|Apr 25, 2022
A Phase 1 study of ADI-PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1-negative metastatic uveal melanoma.

Pui Ying Chan, Melissa M Phillips, Stephen Ellis

|Jun 20, 2020
ctDNA monitoring using patient-specific sequencing and integration of variant reads.

Jonathan C M Wan, Katrin Heider, Davina Gale

|Jun 23, 2017
A major responder to ipilimumab and nivolumab in metastatic uveal melanoma with concomitant autoimmunity.

Pui Ying Chan, Peter Hall, Gordon Hay

Pageof 1

Frequent Collaborators

1 joint publications

Jonathan C M Wan

1 joint publications

Katrin Heider

1 joint publications

Davina Gale

1 joint publications

Eyal Fisher